Home › NDC Lookup › Ingredients › Sodium Hyaluronate › 87298-0037-01
Sodium Hyaluronate Eye Drops .1 g/100g Liquid, 15 g — NDC 87298-0037-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Sodium Hyaluronate Eye Drops .1 g/100g Liquid, 15 g — NDC 87298-037-01 (Billing 87298-0037-01)

by Guangzhou Hechuang Commercial Service Co.,Ltd. · 15 g in 1 BOTTLE, PLASTIC

This is a package of 15 g of Sodium Hyaluronate Eye Drops .1 g/100g Liquid from Guangzhou Hechuang Commercial Service Co.,Ltd., marketed since May 2026 and currently FDA-listed. It is this product's only package size.

NDC 87298-0037-01
🏷️ FDA NDC (as labeled) 87298-037-01 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 87298-037-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
87298 labeler · 037 product · 01 package
Package marketed since
May 11, 2026
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC)
4573638420541
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 87298-037-01
Product NDC 87298-037
11-digit billing NDC 87298003701
RxCUI 2743151
UNII YSE9PPT4TH
UPC 4573638420541
Application # M018
SPL Set ID 5187d136-15c6-517b-e063-6294a90a811d
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2026-05-11
Route OPHTHALMIC
Dosage form LIQUID
Substance SODIUM HYALURONATE
Quick answers
  • RxCUI (RxNorm): 2743151
Why two NDCs? The FDA registers this code as 87298-037-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 87298-0037-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Other cicatrizants class.

Drug family (ATC) Other cicatrizants, Other drugs for disorders of the musculo-skeletal system, Other nasal preparations
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

🧪 What is this product?

Sodium Hyaluronate Eye Drops is a liquid eye drop product available without a prescription as an over-the-counter monograph drug. Sodium hyaluronate is a naturally occurring substance found in the eye that is typically used to lubricate and soothe dry or irritated eyes. This ingredient functions as an artificial tear, helping to coat the eye surface and retain moisture to provide temporary relief from dryness and discomfort.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
87298-0037-01 You're viewing this Main listing 15 g in 1 BOTTLE, PLASTIC 2026-05-11 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Sodium Hyaluronate Eye Drops .1 g/100gthis 87298-0037-01 Guangzhou 15 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2026
On the market since
May 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII P6YC3EG204
    Cyanocobalamin is a synthetic form of vitamin B12. It's used in medicines as a nutritional ingredient and to help maintain the product's stability and potency over time.
  • UNII KV2JZ1BI6Z
    Pyridoxine is a form of vitamin B6, a water-soluble vitamin. It's added to medicines as a nutritional supplement to help maintain adequate B6 levels in the body.
  • UNII 451W47IQ8X
    Sodium chloride is common table salt. It's used in medicines as a buffer to maintain proper pH, as a filler to add bulk, or to adjust the osmotic balance in liquid formulations.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

4 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesWater、sodium chloride、Pyridoxine、Cyanocobalamin

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerGuangzhou Hechuang Commercial Service Co.,Ltd.
FDA applicationM018 (OTC MONOGRAPH DRUG)
Labeler code87298
First marketedMay 2026
Product typeHuman Otc Drug
Portfolio19 products on file

More NDCs from Guangzhou Hechuang Commercial Service Co.,Ltd. labeler code 87298

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children ⚠️ Precautions 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 69 words ▾

Used for dry eye syndrome Relieve dry eye symptoms •The temporary relief of burning and irritation due to dryness of the eye. •The temporary relief of discomfort due to minor irritations of the eye or exposure to wind or sun. •Use as a protectant against further irritation or to relieve dryness of the eye. •Use as a lubricant to prevent further irritation or to relieve dryness of the eye.

⏱️ Dosage and Administration 30 words ▾

Directions To open, Twist and pull tab to remove. •Instill 1 or 2 drops as needed. •If used for dryness and discomfort associated with LASIK, follow your eye doctor's instructions.

⚠️ Warnings 41 words ▾

Warnings •For external use only. •To avoid contamination, do not touch tip of container to any surface. •Use within 30 days after opening. Maintain good hygiene during use and reseal tightly after each use. •If solution changes color, do not use.

🧪 Active Ingredient 5 words ▾

ACTIVE INGREDIENT Sodium Hyaluronate 0.1%

🧪 Inactive Ingredients 4 words ▾

Inactive Ingredients Water、sodium chloride、Pyridoxine、Cyanocobalamin

🎯 Purpose 3 words ▾

Purpose Eye lubricant

📄 Stop Use and Ask a Doctor If 39 words ▾

Stop use and ask a doctor Stop use and ask a doctor. If you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.

📄 Keep Out of Reach of Children 25 words ▾

Keep out of reach of children Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

⚠️ Precautions 27 words ▾

Other Information •Use only if container is intact. •Use before expiration date markedon container. •Store at 59°-86°F (15°-30°C). •Protect from sunlight. •Retain this carton for future reference.

📄 Package Label / Principal Display Panel 3 words ▾

PRINCIPAL DISPLAY PANEL

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Sodium Hyaluronate Eye Drops (this brand).

Top reported reactions

Diarrhoea41
Keratopathy41
Headache35
Vomiting35
Nausea34
Pneumonia31
Pyrexia29

Age at onset

Infant1
Child1
Adolescent2
Adult48
Elderly85

Reporter sex

803 reports
Male · 39%
Female · 61%
Unknown · 0%

Serious outcomes

Hospitalization434
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 86 32
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Guangzhou Hechuang Commercial Service Co.,Ltd.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Guangzhou Hechuang Commercial Service Co.,Ltd. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 87298-0016-01 · Guangzhou 87298-0039-01 · Guangzhou →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.